Xegen Overview
- Founded
-
2012
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Xegen General Information
Description
Developer of bioinformatics tools designed for exhaustive genetic information. The company's platform gives access to all the coding parts of the genome and provides a large overview of coding variations and their phenotypes' consequences, providing physicians with transcriptomic information such as differential expression at a reduced cost.
Contact Information
Website
xegen.fr
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Medical Supplies
Biotechnology
Primary Office
- 15 Rue Dominique Piazza
- Cedex 20
- 13420 Marseille
- France
+33 06 00 00 00 00
Xegen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | Completed | Startup |
Xegen Executive Team (3)
Xegen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Incubateur Impulse | Accelerator/Incubator | 000 0000 | 000000 0 |